Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04717414 |
|---|---|
| Brief Title: | An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions (INDEPENDENCE) |
| First Submitted : | December 29, 2020 |
| First Submitted that Met QC Criteria : | January 15, 2021 |
| First Posted : | January 22, 2021 |
| Last Update Submitted that Met QC Criteria : | May 2, 2024 |
| Last Update Posted : | May 3, 2024 |